Happiness Development Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAPP research report →
About the company
Operating both domestically in the People's Republic of China and across international markets, Happiness Development Group Limited (formerly Happiness Biotech Group Limited until October 2022) specializes in the research, creation, and sale of nutraceuticals and dietary supplements. Their extensive product catalog includes traditional Chinese medicinal extracts like lucidum spore powders, cordyceps mycelia, Ejiao, and American ginseng, alongside a variety of other herbal and animal extracts, vitamins, minerals, and amino acids. Beyond health-focused products, the company provides diverse service offerings.
- CEO
- Xuezhu Wang
- IPO
- 2019
- Employees
- 218
- HQ
- Nanping, CN
Price Chart
- Market Cap
- $31.30M
- P/E
- -0.17
- P/S
- 0.35
- P/B
- 0.12
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
- Gross Margin
- 4.15%
- Op Margin
- -53.16%
- Net Margin
- -60.37%
- ROE
- -62.50%
- ROIC
- -54.43%
- Revenue
- $89.49M · 25.19%
- Net Income
- $-54,020,081 · -7906.87%
- EPS
- $-26.69 · -4548.33%
- Op Income
- $-47,576,051
- FCF YoY
- -3183.72%
- 52W High
- $7.40
- 52W Low
- $2.08
- 50D MA
- $5.11
- 200D MA
- $4.01
- Beta
- 0.22
- Avg Volume
- 16.06K
Get TickerSpark's AI analysis on HAPP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HAPP coverage
Recent articles, reports, and earnings notes.
No research on HAPP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HAPP report →Similar companies
Peers in the same neighborhood.